1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17:253.
2. Mussi-Pinhata MM, Yamamoto AY, Moura Brito RM, et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 2009.
3. Mussi-Pinhata MM, Yamamoto AY, Aragon DC, et al. Seroconversion for Cytomegalovirus Infection During Pregnancy and Fetal Infection in a Highly Seropositive Population: "The BraCHS Study". J Infect Dis 2018; 218:1200.
4. Козлова С.Н., Савельева Е.В. Распространенность герпесвирусных инфекций у детей дошкольного образовательного учреждения / Уральский медицинский журнал. 2015. № 4 (127). С. 45-50..
5. Аистова Л.Г., Провоторов В.Я., Калуцкий П.В. встречаемость вирусов герпетической группы у вич-инфицированных лиц / Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. 2015. № 4 (201). С. 57-60.
6. Баратова М.А., Баратова Д.А., Нурлыханов Е.Б. Иммуногенетические показатели и распространенность носительства вируса Эпштейна -Барр, цитомегаловируса у потенциальных доноров гемопоэтических стволовых клеток / Современные проблемы науки и образования. 2014. № 5. С. 446.
7. Майлян Э.А., Майлян Д.Э. Частота регистрации маркеровцитомегаловирусной инфекции по данным иммуноферментного анализа у жителей донецкого региона / Медико-социальные проблемы семьи. 2013. Т. 18. № 2. С. 123-127.
8. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013; 26: 86-102.
9. Townsend CL, Forsgren M, Ahlfors K, Ivarsson SA, Tookey PA, Peckham CS. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin Infect Dis 2013; 56: 1232-39.
10. Hyde TB, Schmid DS, Cannon MJ. 2010. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev. Med. Virol. 20:311-326.
11. Britt WJ. Congenital human cytomegalovirus infection and the enigma of maternal immunity. J Virol 2017;91(15).
12 .Davis N.L., King C.C., Kourtis A.P. Cytomegalovirus infection in pregnancy. Birth Defects Res 2017;109(5):336-464.
13 .Emery V.C. and Lazzarotto T. Cytomegalovirus in pregnancy and the neonate [version 1; referees: 2 approved] F1000Research 2017, 6(F1000 Faculty Rev):138 (doi: 10.12688/f1000research.10276.1).
14 .Enders G. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. / Enders G., Diaminger A, Bader U et al. // J.Clin.Virol. -2011. -Vol. 52, № 3. -Р. 244-246.
15 .Dar L., Namdeo D., Kumar P., Thakar A., Kant S., Rai S., et al. Congenital cytomegalovirus infection and permanent hearing loss in children in rural north India. Pediatr Infect Dis J 2017;36(7):670-3.
16 .Ross SA, Arora N, Novak Z, Fowler KB, Britt WJ, Boppana SB. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis 2010; 201: 386-89.
17 . Yamamoto AY, Mussi-Pinhata MM, Boppana SB, et al. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 2010; 202: 297 e1-8.
18 .Volpe J.J. Neurology of the newborn. 5th edition. Saunders Elsevier, 2008; 1094.
19 . Buonsenso D., Serranti D., Gargiullo L., Ceccarelli M., Ranno O., Valentini P. Congenital cytomegalovirus infection: current strategies and future perspectives. Eur Rev Med Pharmacol Sci 2012; (16): 919-935.
20 .Hayakawa J., Kawakami Y., Takeda S., Ozawa H, Fukazawa R., Takase M., Fukunaga Yu. A neonate with reduced cytomegalovirus DNA copy number and marked improvement of hearing in the treatment of congenital cytomegalovirus infection. J Nippon Med Sch 2012; (79): 471-477.
21 . Nishida K., Morioka I., Nakamachi Y., Kobayashi Y., Imanishi T., Kawano S. et al. Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment. Brain Dev 2015, .DOI:.org/10.1016/j.braindev.2015.08.003.
22 .Alarcon A., Martinez-Biarge M., Cabanas F., Hernanz A., Quero J., Garcia-Alix A. Clinical, Biochemical, and Neuroimaging Findings Predict LongTerm Neurodevelopmental Outcome in Symptomatic Congenital Cytomegalovirus Infection. J Pediatr 2013; 163: 828-834. DOI: 10.1016/j.jpeds.2013.03.014.
23 . Halwachs-Baumann G. (Ed.). Congenital Cytomegalovirus Infection. Epidemiology, Diagnosis, Therapy. SpringerWienNewYork, 2011; 149.
24 . Bernard S., Wiener-Vacher S., Abbeele T.V.D., Teissier N. Disorders in Children With Congenital Cytomegalovirus Infection. Pediatrics 2015; 136: (4): e887-895.
25 . Dreher A.M., Arora N., Fowler K.B., Novak Z., Britt W.J., Boppana S.B., Ross S.A. Spectrum of Disease and Outcome in Children with Symptomatic Congenital Cytomegalovirus Infection. J Pediatr 2014; 164: (4): 855-859. DOI: 10.1016/j. jpeds.2013.12.007.
26 .Duval M., Park A.H. Congenital cytomegalovirus: what the otolaryngologist should know. Curr Opin Otolaryngol Head Neck Surg 2014; (22): 495-500.
27 .Luck S. Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management./ Luck S., Wieringa J., Blazquez-Gamero D., Henneke P., Schuster K., Butler K., Capretti M., Cilleruelo M., et al.// Pediatr Infect Dis J. 2017 Dec;36(12):1205-1213. doi: 10.1097/INF.0000000000001763.
28 .Boppana S., Ross S., Fowler K.. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis 2013, 57( Suppl 4): S178- S181.
29 . Goderis J., De Leenheer E., Smets K., Van Hoecke H., Keymeulen A., Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics 2014; 134: (5): 972-982. DOI: 10.1542/peds.2014-1173.
30 .Stagno S, Pass RF, Thomas JP, Navia JM, Dworsky ME. Defects of tooth structure in congenital cytomegalovirus infection./ Pediatrics. 1982 May;69(5):646-8.